Qtrypta FDA Approval Status
Last updated by Judith Stewart, BPharm on Jan 21, 2020.
FDA Approved: No
Brand name: Qtrypta
Generic name: zolmitriptan
Company: Zosano Pharma Corporation
Treatment for: Migraine
Qtrypta is a proprietary formulation of zolmitriptan that utilizes Dermally-Applied Microarray (ADAM) technology (drug-coated microneedles) in development for the acute treatment of migraine.
Development timeline for Qtrypta
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.